2012
DOI: 10.1016/j.neuropharm.2012.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
18
0
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 75 publications
1
18
0
1
Order By: Relevance
“…In mammals, the effects of cannabinoid substances in antinociception are also mediated by the activation of CB1 receptors in specific nociception-related central structures, which activates descending nociception control pathways [5]. In rodent models of acute nociception, cannabinoids acting via CB1 receptors, inhibit responses to noxious thermal [22] and mechanical [23] stimuli, as well as the nociceptive response to the formalin test [24][25][26]. This is the first evidence of the involvement of cannabinoid system in modulation of antinociception in fish.…”
Section: Discussionmentioning
confidence: 72%
“…In mammals, the effects of cannabinoid substances in antinociception are also mediated by the activation of CB1 receptors in specific nociception-related central structures, which activates descending nociception control pathways [5]. In rodent models of acute nociception, cannabinoids acting via CB1 receptors, inhibit responses to noxious thermal [22] and mechanical [23] stimuli, as well as the nociceptive response to the formalin test [24][25][26]. This is the first evidence of the involvement of cannabinoid system in modulation of antinociception in fish.…”
Section: Discussionmentioning
confidence: 72%
“…Exogenous administration locally in the paw skin of both AEA and 2-AG in rats with partial sciatic nerve ligation (PNL)- or diabetes-induced neuropathic pain and intrathecally into the spinal cord of rats with CCI-induced neuropathic pain have produced antihyperalgesic activities (Guindon and Beaulieu, 2006; Desroches et al, 2008; Schreiber et al, 2012; Starowicz et al, 2012; Desroches et al, 2014). In the current study, systemic administration (i.p.)…”
Section: Discussionmentioning
confidence: 99%
“…AEA has been reported to produce its antinociceptive effects via activation of both CB1 and CB2 receptors (Schreiber et al, 2012). However, other studies have shown that AEA produces its antinociceptive effects via activation of CB1 receptors but not CB2 receptors (Calignano et al, 1998; Guindon and Beaulieu, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Many studies have shown that the antinociceptive activity of various drugs is attenuated by cannabinoid (Gühring et al, 2002;Guindon et al, 2006;Malan et al, 2001;Schreiber et al, 2012) or opioid (Lembeck and Donnerer, 1985;Hong and Abbott, 1995;Zhao et al, 2003) receptor antagonists. Regarding the receptor subtypes involved, there is evidence for the involvement of both CB1 and CB2 and various opioid receptors.…”
Section: Discussionmentioning
confidence: 99%